The stocks whose daily moves over the past year went most closely with 326030.KS's: the correlation of their daily returns, where 1 would be moving as one.
From the 4Search instruments index: what each company does (its business description), its industry, size, headquarters and the markets it serves; and from a year of daily prices, which move together. Prices may be delayed up to 20 min.
Seoul Economic Daily SK Biopharmaceuticals (326030.KS) shared its experience developing and commercializing cenobamate, an epilepsy treatment, with pharmaceutical and biotechnology experts in the United States The company said on the 12th…
Published 05 Oct.2026 18:31(KST) This year, out of the top 10 major pharmaceutical and biotech deals in the Asia-Pacific region, three deals involved Korean companies, including Samsung BioLogics, SK Biopharmaceuticals, and Hanmi…
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 3 articles, not a forecast.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use.
asiae.co.kr1
biz.chosun.com1
en.sedaily.com1